A phase IV randomised study to assess the tolerability of artesunate-amodiaquine (AS-AQ) (Winthrop® fixed dose combination [FDC]) and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2008
This article has no abstract
Epistemonikos ID: 38d9153acbfa8b8d60252604710cc96ab96e9d28
First added on: Jan 17, 2025